Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

COX2 genetic variation, NSAIDs, and advanced prostate cancer risk.

Cheng I, Liu X, Plummer SJ, Krumroy LM, Casey G, Witte JS.

Br J Cancer. 2007 Aug 20;97(4):557-61. Epub 2007 Jul 3.

2.

MIC1 and IL1RN genetic variation and advanced prostate cancer risk.

Cheng I, Krumroy LM, Plummer SJ, Casey G, Witte JS.

Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1309-11. No abstract available.

3.

Ascending the learning curve--MSI testing experience of a six-laboratory consortium.

Lindor NM, Smalley R, Barker M, Bigler J, Krumroy LM, Lum-Jones A, Plummer SJ, Selander T, Thomas S, Youash M, Seminara D, Casey G, Bapat B, Thibodeau SN.

Cancer Biomark. 2006;2(1-2):5-9.

PMID:
17192055
4.

Podocalyxin variants and risk of prostate cancer and tumor aggressiveness.

Casey G, Neville PJ, Liu X, Plummer SJ, Cicek MS, Krumroy LM, Curran AP, McGreevy MR, Catalona WJ, Klein EA, Witte JS.

Hum Mol Genet. 2006 Mar 1;15(5):735-41. Epub 2006 Jan 24.

PMID:
16434482
5.

Prostate cancer aggressiveness locus on chromosome segment 19q12-q13.1 identified by linkage and allelic imbalance studies.

Neville PJ, Conti DV, Krumroy LM, Catalona WJ, Suarez BK, Witte JS, Casey G.

Genes Chromosomes Cancer. 2003 Apr;36(4):332-9.

PMID:
12619157
6.

RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases.

Casey G, Neville PJ, Plummer SJ, Xiang Y, Krumroy LM, Klein EA, Catalona WJ, Nupponen N, Carpten JD, Trent JM, Silverman RH, Witte JS.

Nat Genet. 2002 Dec;32(4):581-3. Epub 2002 Nov 4.

PMID:
12415269
7.

Breast tumor immunophenotype of BRCA1-mutation carriers is influenced by age at diagnosis.

Vaziri SA, Krumroy LM, Elson P, Budd GT, Darlington G, Myles J, Tubbs RR, Casey G.

Clin Cancer Res. 2001 Jul;7(7):1937-45.

8.

Frequency of BRCA1 and BRCA2 mutations in a clinic-based series of breast and ovarian cancer families.

Vaziri SA, Krumroy LM, Rostai M, Casey G.

Hum Mutat. 2001;17(1):74.

PMID:
11139249
9.

Germline BRCA1 alterations in a population-based series of ovarian cancer cases.

Janezic SA, Ziogas A, Krumroy LM, Krasner M, Plummer SJ, Cohen P, Gildea M, Barker D, Haile R, Casey G, Anton-Culver H.

Hum Mol Genet. 1999 May;8(5):889-97.

Supplemental Content

Loading ...
Support Center